Articles / venture-startup-funding / Glass House Brands Reports First Quarter 2026 Financial Results
Glass House Brands Reports First Quarter 2026 Financial Results
Q1 2026 Revenue
$40.5 million
Total revenue reported for the first quarter of 2026.
Average Selling Price
$171 per pound
Average price per pound of cannabis sold in Q1 2026.
Projected Cannabis Biomass Production
1,000,000 pounds
Estimated total cannabis biomass production for the year 2026.
⦿ Executive Snapshot
- What: Glass House Brands reports Q1 2026 financial results with a revenue of $40.5 million.
- Who: Glass House Brands Inc., Kyle Kazan (Co-Founder, Chairman and CEO).
- Why it matters: The report highlights significant challenges in production costs and pricing, alongside potential regulatory shifts that could impact future operations and profitability.
⦿ Key Developments
- Revenue for Q1 2026 was $40.5 million, a decrease from $44.8 million in Q1 2025 and $38.9 million in Q4 2025.
- The average selling price was $171 per pound, down from $193 in Q1 2025.
- The company anticipates producing approximately 1,000,000 pounds of cannabis biomass in 2026, maintaining its full-year guidance.
⦿ Strategic Context
- Glass House Brands operates in a challenging California cannabis market, facing reduced wholesale prices and increased production costs.
- The recent rescheduling of medical cannabis under Schedule III may provide opportunities for tax relief and market expansion, significantly impacting growth potential.
⦿ Strategic Implications
- Immediate implications include a need to adjust operations to manage rising production costs and competitive pricing pressures.
- Long-term, the potential deregulation and market expansion could lead to increased revenue and profitability if executed effectively.
⦿ Risks & Constraints
- Potential risks include regulatory uncertainties and dependence on the successful implementation of new operational strategies amid a fluctuating market.
- Competition from other cannabis producers and the necessity to innovate in product offerings may constrain growth.
⦿ Watchlist / Forward Signals
- Key upcoming milestones include the completion of the Greenhouse 2 build-out and the anticipated regulatory changes regarding medical cannabis.
- The effectiveness of the newly launched ATM program for capital raising will be crucial for funding future expansions and operations.
§ 08
Related Articles
Zealand Pharma Announces Financial Results for the First Half of 2026
§ 01 Executive Snapshot What: Zealand Pharma announced its financial results for the first half of 2
google.com
Acorns acquires family investment app EarlyBird
§ 01 Executive Snapshot What: Acorns has acquired the family investment app EarlyBird. Who: Acorns a
fintechfutures.com
POET Technologies Reports Second Quarter 2026 Results:
§ 01 Executive Snapshot What: POET Technologies reports strong financial results for Q2 2026, showca
google.com
Bending Spoons announces Q2 2026 results
§ 01 Executive Snapshot What: Bending Spoons S.p.A. announced its impressive Q2 2026 financial resul
google.com